National multicentric M13 Stem Cell Trial reports negative outcome - Need to look at VSELs as an alternative to bone marrow MNCs for cardiac regeneration
- PMID: 27748311
- PMCID: PMC5094126
- DOI: 10.4103/0971-5916.192080
National multicentric M13 Stem Cell Trial reports negative outcome - Need to look at VSELs as an alternative to bone marrow MNCs for cardiac regeneration
Conflict of interest statement
None.
References
-
- Seth S, Narang R, Bhargava B, Ray R, Mohanty S, Gulati G, et al. AIIMS Cardiovascular Stem Cell Study Group. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J Am Coll Cardiol. 2006;48:2350–1. - PubMed
-
- Reardon S. NIH stem-cell programme closes. Nature. 2014;508:157. - PubMed
-
- Abbott A. Doubts over heart stem-cell therapy. Nature. 2014;509:15–6. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources